Skip to content

MyoVision Software Feature Pack D

by Precision Biometrics Inc

MyoVision Software Feature Pack D is a Class I device made by Precision Biometrics Inc, cleared under FDA 510(k) K123399 on 1 Aug 2013 and listed in FDA GUDID since 27 Nov 2016 (UDI-DI 00853818007095), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K123399

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00853818007095 UDI-DI Date27 Nov 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK123399 Date1 Aug 2013DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K123399 decided 1 Aug 2013 Active
  • FDA GUDID UDI-DI 00853818007095 listed 27 Nov 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K123399
  2. Listed FDA GUDID 00853818007095

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
MyoVision Software
Generic name
Bioelectrical signal analysis software
Model / reference
Feature Pack D
Primary DI / UDI-DI
00853818007095
510(k) Number
FDA product code
KQX, HCS, HCC, IKN
GMDN term
Bioelectrical signal analysis software
Device class
Class I
Regulation number
888.1500, 882.1570, 882.5050, 890.1375
GUDID distribution status
In Commercial Distribution

Other devices from Precision Biometrics Inc

See all devices from Precision Biometrics Inc →

Properties

  • Prescription use
  • Lot / batch number
Other properties (13, all answered No)